Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 1999Journal of Clinical InvestigationOpen Access

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRichard M. LawnSomaLogic (United States)DWDavid P. WadeEmory UniversityMGMichael R. GarvinUniversity of North Carolina at Charlotte

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lawn et al. (1999) studied this question.

synapsesocial.com/papers/6a1dd5fccd67cee37334ea59https://doi.org/10.1172/jci8119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cyclic AMP Induces Apolipoprotein E Binding Activity and Promotes Cholesterol Efflux from a Macrophage Cell Line to Apolipoprotein Acceptors1996 · 198 citations
  2. 2Interleukin-1β Secretion Is Impaired by Inhibitors of the Atp Binding Cassette Transporter, ABC11997 · 226 citations
  3. 3LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis1983 · 2,312 citations
  4. 4Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion1997 · 109 citations
  5. 5Cell cholesterol efflux: integration of old and new observations provides new insights1999 · 504 citations